Edition:
United Kingdom

Insider Trading: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

43.82USD
18 Jun 2019
Change (% chg)

$-13.54 (-23.61%)
Prev Close
$57.36
Open
$41.51
Day's High
$45.95
Day's Low
$40.82
Volume
956,211
Avg. Vol
150,007
52-wk High
$67.86
52-wk Low
$29.17

All Insider Trades
Trading Date Name Title Type Shares Traded Price
16 Apr 2019

Doogan (Declan)

Director Sell 50,000 $61.92
12 Apr 2019

Doogan (Declan)

Director Sell 38,825 $53.92
26 Mar 2019

Doogan (Declan)

Director Sell 5,824 $53.72
25 Mar 2019

Bailey (Gregory Hugh)

Director Buy 107,500 $9.29
22 Mar 2019

Childs John W

Director Buy 107,500 $9.29
22 Mar 2019

Doogan (Declan)

Director Sell 5,351 $53.66
14 Mar 2019

Coric (Vlad M.D.)

Chief Executive Officer Sell 16,110 $50.02
14 Mar 2019

Coric (Vlad M.D.)

Chief Executive Officer Sell 15,783 $50.03
13 Mar 2019

Coric (Vlad M.D.)

Chief Executive Officer Sell 7,883 $50.02
13 Mar 2019

Coric (Vlad M.D.)

Chief Executive Officer Sell 8,262 $50.02
12 Mar 2019

Coric (Vlad M.D.)

Chief Executive Officer Sell 26,007 $50.15
12 Mar 2019

Coric (Vlad M.D.)

Chief Executive Officer Sell 25,955 $50.15
12 Mar 2019

Tilton (John)

Officer Buy 10,000 $9.29
12 Mar 2019

Tilton (John)

Officer Sell 10,000 $50.11
1 Mar 2019

Doogan (Declan)

Director Sell 50,000 $47.19
1 Mar 2019

Doogan (Declan)

Director Sell 595 $45.41
27 Feb 2019

Doogan (Declan)

Director Sell 23,384 $45.71
27 Feb 2019

Doogan (Declan)

Director Sell 1,900 $45.86
27 Feb 2019

Doogan (Declan)

Director Sell 18,270 $45.25
27 Feb 2019

Doogan (Declan)

Director Sell 6,875 $44.17
26 Feb 2019

Doogan (Declan)

Director Sell 20,796 $44.31
26 Feb 2019

Doogan (Declan)

Director Sell 100 $44.81
25 Feb 2019

Doogan (Declan)

Director Sell 13,943 $45.49
25 Feb 2019

Doogan (Declan)

Director Sell 20,334 $45.25
25 Feb 2019

Doogan (Declan)

Director Sell 100 $45.74

Institutional Holders

% Shares Owned: 92.34%
# of Holders: 231
Total Shares Held: 40,995,957
3 Mo. Net Change: 374,749
# New Positions: 57
# Closed Positions: 14
# Increased Positions: 132
# Reduced Positions: 65
# Net Buyers: 67

Officers & Directors

Name Age Since Current Position

Declan Doogan

67 Independent Chairman of the Board

Vlad Coric

48 2015 Chief Executive Officer, Director

James Engelhart

55 2016 Chief Financial Officer, Treasurer

Kimberly Gentile

53 2014 Senior Vice President - Clinical Operations

Charles Conway

57 2017 Chief Scientific Officer

Robert Berman

56 2015 Chief Medical Officer

John Tilton

51 2019 Chief Commercial Officer, Rare and Orphan Diseases

Gregory Bailey

63 2014 Director

John Childs

77 2014 Director

Robert Repella

60 2018 Director

Eric Aguiar

57 2017 Independent Director

Julia Gregory

66 2017 Independent Director